Press Release
Press Release
Exelixis Announces Webcast of Annual R&D Day on December 1
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov. 17, 2011--
In addition, leading oncology experts will share their perspectives on cabozantinib, as well as the evolving treatment landscapes for castration-resistant prostate cancer and medullary thyroid cancer. Presenters will include:
Matthew Smith M.D ., Ph.D., Professor of Medicine and Director of the Genitourinary Malignancies Program at theMassachusetts General Hospital Cancer Center Daniel J. George , M.D., Director of Genitourinary Medical Oncology and Director of theProstate Clinic ,Duke University Medical Center Howard Scher , M.D., Chief of the Genitourinary Oncology Service, theSidney Kimmel Center for Urologic and Prostate Cancers atMemorial Sloan-Kettering Cancer Center Ethan Basch , M.D., Associate Attending Physician atMemorial Sloan-Kettering Cancer Center Steven I. Sherman , M.D., Chair and Naguib Samaan Distinguished Professor in Endocrinology and Medical Director, Endocrine Multidisciplinary Center atMD Anderson Cancer Center
The event will be webcast and may be accessed in the Event Calendar page under Investors at http://www.exelixis.com. It will also be archived at that location for a minimum of 30 days.
About
Source:
Exelixis, Inc.
Charles Butler, 650-837-7277
Vice President, Investor Relations and Corporate Communications
cbutler@exelixis.com